Transition to adult care of young patients with neurofibromatosis type 1 and cognitive deficits: a single-centre study.
Cognitive deficits
Neurofibromatosis type 1
Psychiatric comorbidities
Transition
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
21 05 2022
21 05 2022
Historique:
received:
09
12
2021
accepted:
08
05
2022
entrez:
21
5
2022
pubmed:
22
5
2022
medline:
25
5
2022
Statut:
epublish
Résumé
The transition of adolescents to adult care is known to be challenging. Studies indicate that patients with a chronic disease and cognitive deficits are at risk of inadequate transition to adult care, which eventually may result in disease deterioration. This study investigated the transition process for patients with neurofibromatosis type 1 (NF1) and discussed whether patients with NF1 and cognitive deficits should receive additional attention in their transitional period. A self-reported online questionnaire assessing disease severity, cognitive deficits, psychiatric diagnoses as well as transition experiences was completed by patients with NF1 aged 15-25-years. Patients were assigned to a national NF1 expert centre covering the western part of Denmark. Furthermore, a retrospective medical chart review was performed, and data were collected to estimate the prevalence of psychiatric diagnoses. The questionnaire was completed by 41/103 (39%), median age 20 [range 15; 25] years. Medical chart review was performed in 103 patients, median age 20 [range 15; 25]. Participants reporting the transition as difficult all received special needs education, six reported executive function deficits and three out of seven had a psychiatric diagnosis. Fifteen (37%) questionnaire participants reported a wish for more information about the natural history and the prognosis of NF1. The prevalence of psychiatric diagnoses was 24% in the questionnaire survey and 30% in the medical chart review. This study suggests a need of additional care for patients with NF1 and cognitive deficits including psychiatric disorders during their transition to adult care. In addition, it suggests a need for more information on and education in long-term prospects and mental health issues for patients with NF1.
Sections du résumé
BACKGROUND
The transition of adolescents to adult care is known to be challenging. Studies indicate that patients with a chronic disease and cognitive deficits are at risk of inadequate transition to adult care, which eventually may result in disease deterioration. This study investigated the transition process for patients with neurofibromatosis type 1 (NF1) and discussed whether patients with NF1 and cognitive deficits should receive additional attention in their transitional period.
METHOD
A self-reported online questionnaire assessing disease severity, cognitive deficits, psychiatric diagnoses as well as transition experiences was completed by patients with NF1 aged 15-25-years. Patients were assigned to a national NF1 expert centre covering the western part of Denmark. Furthermore, a retrospective medical chart review was performed, and data were collected to estimate the prevalence of psychiatric diagnoses.
RESULTS
The questionnaire was completed by 41/103 (39%), median age 20 [range 15; 25] years. Medical chart review was performed in 103 patients, median age 20 [range 15; 25]. Participants reporting the transition as difficult all received special needs education, six reported executive function deficits and three out of seven had a psychiatric diagnosis. Fifteen (37%) questionnaire participants reported a wish for more information about the natural history and the prognosis of NF1. The prevalence of psychiatric diagnoses was 24% in the questionnaire survey and 30% in the medical chart review.
CONCLUSION
This study suggests a need of additional care for patients with NF1 and cognitive deficits including psychiatric disorders during their transition to adult care. In addition, it suggests a need for more information on and education in long-term prospects and mental health issues for patients with NF1.
Identifiants
pubmed: 35597953
doi: 10.1186/s13023-022-02356-z
pii: 10.1186/s13023-022-02356-z
pmc: PMC9123681
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
208Informations de copyright
© 2022. The Author(s).
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Dev Med Child Neurol. 2017 Nov;59(11):1112-1116
pubmed: 28845518
Dev Med Child Neurol. 2002 Mar;44(3):164-70
pubmed: 12005317
Nat Rev Dis Primers. 2017 Feb 23;3:17004
pubmed: 28230061
Am J Med Genet A. 2013 Apr;161A(4):659-66
pubmed: 23427176
Pediatrics. 2005 Jan;115(1):112-20
pubmed: 15629990
Arch Dis Child. 2011 Jun;96(6):548-53
pubmed: 21388969
Int J Psychiatry Clin Pract. 2021 Nov;25(4):350-355
pubmed: 34270353
Pediatrics. 2013 Dec;132(6):e1642-8
pubmed: 24190681
Am J Med Genet A. 2018 May;176(5):1150-1160
pubmed: 29681082
Am J Med Genet A. 2013 Jul;161A(7):1666-74
pubmed: 23696535
Epilepsy Behav. 2019 Jul;96:23-27
pubmed: 31077938
J Adolesc Health. 2013 Jun;52(6):670-81
pubmed: 23701887
JAMA Pediatr. 2016 Mar;170(3):205-11
pubmed: 26619178
Am J Med Genet A. 2020 Jul;182(7):1704-1715
pubmed: 32484306
Curr Opin Pediatr. 2008 Aug;20(4):403-9
pubmed: 18622194
Neurofibromatosis. 1988;1(3):172-8
pubmed: 3152465